Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126573152 | 12657315 | 2 | F | 20160831 | 20160816 | 20160907 | EXP | CN-SA-2016SA147882 | AVENTIS | XING C, GE B, YU K, GAO S, LIANG B, YE H. BLOODSTREAM INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIA CARBAPENEMASE 2-PRODUCING K. PNEUMONIAE AT A HEMATOLOGY DEPARTMENT IN WENZHOU, CHINA. INTERN MED. 2016 JAN 01;55(15):2087-91. DOI: 10.2169/INTERNALMEDICINE.55.6369 | 40.00 | YR | A | M | Y | 0.00000 | 20160907 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126573152 | 12657315 | 1 | SS | DEXAMETHASONE SALT NOT SPECIFIED | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
126573152 | 12657315 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
126573152 | 12657315 | 3 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | UNK | 0 | ||||||||||
126573152 | 12657315 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
126573152 | 12657315 | 5 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | U | UNK | 21759 | |||||||||
126573152 | 12657315 | 6 | SS | IMIPENEM/CILASTATIN SODIUM | CILASTATIN SODIUMIMIPENEM | 1 | Unknown | Y | UNK | 0 | |||||||||
126573152 | 12657315 | 7 | SS | FOSFOMYCIN SALT NOT SPECIFIED | FOSFOMYCIN | 1 | Intravenous (not otherwise specified) | Y | UNK | 0 | |||||||||
126573152 | 12657315 | 8 | SS | MOXIFLOXACIN HYDROCHLORIDE. | MOXIFLOXACIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
126573152 | 12657315 | 9 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Unknown | UNK | 0 | ||||||||||
126573152 | 12657315 | 10 | SS | MITOXANTRONE | MITOXANTRONE HYDROCHLORIDE | 1 | Unknown | U | UNK | 0 | |||||||||
126573152 | 12657315 | 11 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | UNK | 0 | |||||||||
126573152 | 12657315 | 12 | SS | TIGECYCLINE. | TIGECYCLINE | 1 | Intravenous (not otherwise specified) | Y | UNK | 0 | 200 | MG | 1X | ||||||
126573152 | 12657315 | 13 | SS | TIGECYCLINE. | TIGECYCLINE | 1 | Intravenous (not otherwise specified) | Y | UNK | 0 | 100 | MG | Q12H | ||||||
126573152 | 12657315 | 14 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | UNK | 0 | ||||||||||
126573152 | 12657315 | 15 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
126573152 | 12657315 | 16 | SS | SULBACTAM/CEFOPERAZONE | CEFOPERAZONESULBACTAM | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
126573152 | 12657315 | 17 | C | VORICONAZOLE. | VORICONAZOLE | 1 | 0 | ||||||||||||
126573152 | 12657315 | 18 | C | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
126573152 | 12657315 | 19 | C | IMIPENEM/CILASTATIN SODIUM | 2 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126573152 | 12657315 | 1 | T-cell lymphoma |
126573152 | 12657315 | 2 | T-cell lymphoma |
126573152 | 12657315 | 3 | T-cell lymphoma |
126573152 | 12657315 | 4 | T-cell lymphoma |
126573152 | 12657315 | 5 | T-cell lymphoma |
126573152 | 12657315 | 6 | Klebsiella bacteraemia |
126573152 | 12657315 | 7 | Pneumonia klebsiella |
126573152 | 12657315 | 8 | Infection |
126573152 | 12657315 | 9 | T-cell lymphoma |
126573152 | 12657315 | 10 | T-cell lymphoma |
126573152 | 12657315 | 11 | T-cell lymphoma |
126573152 | 12657315 | 12 | Klebsiella bacteraemia |
126573152 | 12657315 | 13 | Klebsiella bacteraemia |
126573152 | 12657315 | 14 | Infection |
126573152 | 12657315 | 15 | Infection |
126573152 | 12657315 | 16 | Infection |
126573152 | 12657315 | 17 | Infection |
126573152 | 12657315 | 18 | Infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126573152 | 12657315 | OT |
126573152 | 12657315 | DE |
126573152 | 12657315 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126573152 | 12657315 | C-reactive protein increased | |
126573152 | 12657315 | Klebsiella bacteraemia | |
126573152 | 12657315 | Lymphadenopathy | |
126573152 | 12657315 | Malignant neoplasm progression | |
126573152 | 12657315 | Multiple-drug resistance | |
126573152 | 12657315 | Pathogen resistance | |
126573152 | 12657315 | Pyrexia | |
126573152 | 12657315 | T-cell lymphoma | |
126573152 | 12657315 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |